Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myeloid leukemia factor 2 pseudogene (LOC100419977, ENSG00000253942) is a non-protein-coding genomic locus that is homologous to the functional gene myeloid leukemia factor 2 (MLF2). As a pseudogene, it is not expected to produce a functional protein product nor act as a direct therapeutic target[1][7][8]. Like other processed pseudogenes, it may potentially participate in regulation of gene expression through RNA-related mechanisms, such as competing for microRNA binding or serving as a decoy, although no direct functional evidence is available for this specific pseudogene[2][5]. The parental gene MLF2 is involved in transcription regulation and is associated with leukemia, but the pseudogene itself does not have a confirmed disease association, nor does it interact with known drugs[1][4]. This entry should be considered as a genomic non-coding element rather than a druggable target or marker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myeloid leukemia factor 2 pseudogene.